VG Somani Drug Controller General of India, gave approval for covid vaccine on Sunday. Serum Institute of India’s ‘Covid Vaccine’ vaccine and Bharat Biotech’s ‘Covaxin’ have been given approval for emergency use. India has the second highest number of covid cases in the world and this is definitely going to be a good news.
In the coming six to eight months the Central Government is planning to vaccinate nearly 30 crore people in the first phase. The first to get vaccinated will be frontline workers, essential workers, health care workers and elderly people who are above the age of 50 years.
Serum Institute of India which is a Pune based company has partnered with Oxford Astra Zeneca for clinical trials and has come-up with ‘Covishield’ Vaccine while ‘Covaxin’ was manufactured by Bharat Biotech in collaboration with Indian Council of Medical Research.
Covishield Vaccine is already approved by the United Kingdom and Argentina. Five crore plus doses have already been stocked by the manufacturer, serum Institute of India. Covishield vaccine has a crucial role to play in India’s vaccination process because of its many advantages such as easy storage, easy transportation and is economical.
India is going to receive a major share of the vaccines that are stocked by Serum Institute of India, finally, Great news for everyone in the beginning of New Year.